CLINICALLY ISOLATED SYNDROME
Clinical trials for CLINICALLY ISOLATED SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CLINICALLY ISOLATED SYNDROME trials appear
Sign up with your email to follow new studies for CLINICALLY ISOLATED SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early MS drug may alter brain inflammation signals
Disease control OngoingThis study examines whether starting the medication ocrelizumab very early after a first MS symptom changes markers of inflammation in the spinal fluid. It involves 30 newly diagnosed adults who will receive the drug every 6 months for 3 years. The goal is to see if early, strong…
Matched conditions: CLINICALLY ISOLATED SYNDROME
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Can diet and exercise rival MS drugs? new study investigates
Disease control OngoingThis study aims to find out if a comprehensive lifestyle program—including a specific diet, exercise, and stress reduction—can be as effective as standard drug treatments for people newly diagnosed with multiple sclerosis (MS) or its early stage (CIS). It follows 44 participants …
Matched conditions: CLINICALLY ISOLATED SYNDROME
Phase: NA • Sponsor: Terry L. Wahls • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
AI brain scan tool aims to sharpen MS detection
Diagnosis ENROLLING_BY_INVITATIONThis study is testing whether a special AI software that analyzes brain MRI scans helps doctors better detect disease activity in people with multiple sclerosis (MS). It will compare standard care with and without the AI tool in 750 patients to see if it improves decision-making …
Matched conditions: CLINICALLY ISOLATED SYNDROME
Phase: NA • Sponsor: icometrix • Aim: Diagnosis
Last updated Apr 03, 2026 14:43 UTC